NCT00383773

Brief Summary

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2006

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2006

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

October 3, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 4, 2006

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

October 4, 2006

Status Verified

September 1, 2006

First QC Date

October 3, 2006

Last Update Submit

October 3, 2006

Conditions

Keywords

retinal vein occlusionrTPA

Outcome Measures

Primary Outcomes (2)

  • Visual acuity

  • Amount of macular edema.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • crvo less than 6 month
  • Visual Acuity less than 6/21
  • No prior eye surgery except cataract.

You may not qualify if:

  • Retinal/iris neovascularization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Retinal Vein Occlusion

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesVenous ThrombosisThrombosisEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Officials

  • Michael halpert

    Hadassah Medical Organization

    STUDY CHAIR

Central Study Contacts

Michael Halpert, MD.

CONTACT

Hadas Lemberg, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 3, 2006

First Posted

October 4, 2006

Study Start

October 1, 2006

Study Completion

October 1, 2007

Last Updated

October 4, 2006

Record last verified: 2006-09